Home Infusion Therapy Devices Market Revenue, Trends, Market Share Analysis, and Forecast to 2030

Comments · 46 Views

The home infusion therapy devices market was valued USD 29.9 Billion in 2021 and is projected to reach USD 60.1 billion by 2030 at CAGR of 7.4% over the forecast period 2022-2030.

The home infusion therapy devices market was valued USD 29.9 Billion in 2021 and is projected to reach USD 60.1 billion by 2030 at CAGR of 7.4% over the forecast period 2022-2030. Home infusion therapy devices are devices that are used to deliver medications through a needle or catheter into a vein inside the home setting.

Segmentation

The global home infusion therapy devices market has been segmented into product and application.

By product, the market has been segmented into infusion pumps, intravenous sets, IV cannulas, needleless connectors, elastomeric pumps, and others. The intravenous sets segment is expected to register the highest CAGR during the forecast period due to growing demand.

On the basis of application, the market has been segmented into anti-infectives, endocrinology, enteral nutrition, chemotherapy, hydration therapy, parenteral infusion, and others.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7906

Key Players

Some of the prominent players in the global home infusion therapy devices market are B. Braun Melsungen AG, Fresenius Kabi AG, Baxter International Inc., Johnson Johnson Private Limited, Pfizer Inc., Terumo Corporation, Smith Nephew, and Care Fusion Corporation.

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global home infusion therapy devices market owing to the owing to increasing geriatric population, high prevalence of various chronic diseases, and a large number of diagnostic imaging centers. Additionally, a large number of surgical procedures, along with the fast adoption of technologically advanced home care products is driving the growth of the market. For instance, according to the Center for Diseases Control and Prevention, approximately 46.5 million surgical procedures are performed every year in the US. Additionally, according to the United States Census Bureau, around 49.2 million adults aged 65 and above were present in the US as of 2016.

Europe accounts for the second largest market and holds a healthy share in the global home infusion therapy devices market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing medical device industry due to the presence of major market players.

Asia-Pacific is expected to be the fastest growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies.

The Middle East Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access, and availability of treatment facilities. In the Middle East, the UAE and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers.

Access Report Details @ https://www.marketresearchfuture.com/reports/home-infusion-therapy-devices-market-7906

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments